A S Harris

2.7k total citations
44 papers, 2.1k citations indexed

About

A S Harris is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, A S Harris has authored 44 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 11 papers in Molecular Biology and 10 papers in Physiology. Recurrent topics in A S Harris's work include Electrolyte and hormonal disorders (9 papers), Erythrocyte Function and Pathophysiology (7 papers) and Neonatal Respiratory Health Research (7 papers). A S Harris is often cited by papers focused on Electrolyte and hormonal disorders (9 papers), Erythrocyte Function and Pathophysiology (7 papers) and Neonatal Respiratory Health Research (7 papers). A S Harris collaborates with scholars based in United States, Sweden and Italy. A S Harris's co-authors include Jon S. Morrow, I. M. Nilsson, Stefan Lethagen, Dorothy E. Croall, Zoltán Wagner, Pier Mannuccio Mannucci, A. Fjellestad‐Paulsen, U. Alkner, S Wille and F. J. Hollis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

A S Harris

43 papers receiving 2.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
A S Harris 731 419 402 320 292 44 2.1k
R. Bouillon 840 1.1× 426 1.0× 297 0.7× 113 0.4× 320 1.1× 70 4.2k
L H Block 704 1.0× 613 1.5× 1.0k 2.6× 80 0.3× 163 0.6× 63 2.6k
A C Moses 1.4k 1.9× 311 0.7× 131 0.3× 48 0.1× 191 0.7× 49 3.1k
Olav Tenstad 594 0.8× 271 0.6× 362 0.9× 77 0.2× 259 0.9× 82 2.4k
M. A. Venkatachalam 707 1.0× 332 0.8× 425 1.1× 100 0.3× 207 0.7× 27 2.7k
Stephen F. Kemp 1.1k 1.4× 773 1.8× 216 0.5× 96 0.3× 160 0.5× 107 4.4k
Richard Kremer 1.7k 2.3× 440 1.1× 384 1.0× 236 0.7× 226 0.8× 135 4.3k
Takashi Iida 588 0.8× 469 1.1× 129 0.3× 97 0.3× 144 0.5× 165 2.6k
Göran Granérus 480 0.7× 359 0.9× 463 1.2× 44 0.1× 52 0.2× 137 2.7k
Meinrad Peterlik 1.2k 1.6× 391 0.9× 181 0.5× 77 0.2× 120 0.4× 148 4.4k

Countries citing papers authored by A S Harris

Since Specialization
Citations

This map shows the geographic impact of A S Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A S Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A S Harris more than expected).

Fields of papers citing papers by A S Harris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A S Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A S Harris. The network helps show where A S Harris may publish in the future.

Co-authorship network of co-authors of A S Harris

This figure shows the co-authorship network connecting the top 25 collaborators of A S Harris. A scholar is included among the top collaborators of A S Harris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A S Harris. A S Harris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barros, Andreia S., Soraia Pinto, Juliana Santos Rosa Viegas, et al.. (2024). Orally Delivered Stimulus‐Sensitive Nanomedicine to Harness Teduglutide Efficacy in Inflammatory Bowel Disease. Small. 20(45). e2402502–e2402502. 13 indexed citations
2.
Knox, Claire Connolly & A S Harris. (2016). Evolution of an experiential learning partnership in emergency management higher education. Journal of Emergency Management. 14(3). 201–211. 3 indexed citations
3.
Suter, Melissa, Jun Ma, A S Harris, et al.. (2011). Maternal tobacco use modestly alters correlated epigenome-wide placental DNA methylation and gene expression. Epigenetics. 6(11). 1284–1294. 208 indexed citations
4.
Mamluk, Roni, et al.. (2006). The type 1 repeat peptide ABT510 induces apoptosis of brain microvascular endothelial cells and inhibits glioblastoma tumor growth in vivo. Cancer Research. 66. 54–54. 1 indexed citations
5.
Mamluk, Roni, Irvith M. Carvajal, Steve G. Kovats, et al.. (2005). Preclinical development of a potent VEGFR-2 antagonist based on a novel protein scaffold (AdNectin). Cancer Research. 65. 714–715. 1 indexed citations
6.
Cox, Peter J., David Ryan, F. J. Hollis, et al.. (2000). Absorption, Disposition, and Metabolism of Rosiglitazone, a Potent Thiazolidinedione Insulin Sensitizer, in Humans. Drug Metabolism and Disposition. 28(7). 772–780. 176 indexed citations
7.
Harris, A S, et al.. (1998). Preface. Advanced Drug Delivery Reviews. 29(1-2). 1–1. 1 indexed citations
8.
Scarpa, A L, Roger L. Eddy, M.G. Byers, et al.. (1993). Cloning of a Portion of the Chromosomal Gene and cDNA for Human β-Fodrin, the Nonerythroid Form of β-Spectrin. Genomics. 17(2). 287–293. 13 indexed citations
9.
Lethagen, Stefan, A S Harris, & I. M. Nilsson. (1990). Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type I. Annals of Hematology. 60(3). 187–191. 51 indexed citations
10.
Younes, Mamoun, A S Harris, & Jon S. Morrow. (1989). Fodrin as a differentiation marker. Redistributions in colonic neoplasia.. PubMed. 135(6). 1197–212. 23 indexed citations
11.
Sukhai, R. N., Jacques De Mol, & A S Harris. (1989). Combined therapy of enuresis alarm and desmopressin in the treatment of nocturnal enuresis. European Journal of Pediatrics. 148(5). 465–467. 61 indexed citations
12.
Robertson, Gary L. & A S Harris. (1989). Clinical Use of Vasopressin Analogues. Hospital Practice. 24(10). 114–139. 11 indexed citations
13.
Harris, A S, Mats Ohlin, Elin M. Svensson, Stefan Lethagen, & Inga Marie Nilsson. (1989). Effect of Viscosity on the Pharmacokinetics and Biological Response to Intranasal Desmopressin. Journal of Pharmaceutical Sciences. 78(6). 470–471. 41 indexed citations
14.
Lattuada, A, et al.. (1989). Subcutaneous desmopressin (DDAVP) shortens the bleeding time in uremia. American Journal of Hematology. 31(1). 32–35. 34 indexed citations
15.
Harris, A S. (1989). Clinical experience with desmopressin: Efficacy and safety in central diabetes insipidus and other conditions. The Journal of Pediatrics. 114(4). 711–718. 30 indexed citations
16.
Harris, A S, Mats Ohlin, Stefan Lethagen, & I. M. Nilsson. (1988). Effects of Concentration and Volume on Nasal Bioavailability and Biological Response to Desmopressin. Journal of Pharmaceutical Sciences. 77(4). 337–339. 56 indexed citations
17.
Harris, A S, Elin M. Svensson, Zoltán Wagner, Stefan Lethagen, & Inga Marie Nilsson. (1988). Effect of Viscosity on Particle Size, Deposition, and Clearance of Nasal Delivery Systems Containing Desmopressin. Journal of Pharmaceutical Sciences. 77(5). 405–408. 78 indexed citations
18.
Fjellestad‐Paulsen, A., Nadia Tubiana‐Rufi, A S Harris, & Paul Czernichow. (1987). Central diabetes insipidus in children.. European Journal of Endocrinology. 115(3). 307–312. 20 indexed citations
19.
Harris, A S, Pavo Hedner, & Hans Vilhardt. (1987). Nasal administration of desmopressin by spray and drops. Journal of Pharmacy and Pharmacology. 39(11). 932–934. 22 indexed citations
20.
Warren, John R., A S Harris, & Charles H. Wallas. (1983). Transformation of Human Erythrocyte Shape by Endotoxic Lipopolysaccharide. Infection and Immunity. 39(1). 431–434. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026